Initial commercial availability begins through an Early Experience Program with Penn Highlands Healthcare and Allegheny ...
Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing ...
By creating high-resolution cellular and molecular visual maps of lung cancer before and during development, researchers at ...
4h
If you experience these symptoms repeatedly, you could have lung cancer: “You should see a doctor”
A health campaign urges the public to pay closer attention to subtle warning signs that often go unnoticed in the earliest ...
By creating high-resolution cellular and molecular visual maps of lung cancer before and during development, researchers at ...
Targeted therapies, guided by molecular testing, offer significant benefits, including fewer side effects and personalization ...
Cellular therapies, including TIL, TCR, and CAR-T, are transforming lung cancer care by utilizing personalized immune cells ...
Initial commercial availability begins through an Early Experience Program with Penn Highlands Healthcare and Allegheny Health Network – SAN ...
CAT scans detecting cancer is nothing new. But now, doctors are using artificial intelligence to spot cancer even sooner.
Spatial maps of lung precancer and cancer cells at different points in development advance understanding of the earliest ...
Cancer Research is backing the first-in-human trial of LungVax, a preventative vaccine designed to prime the immune system ...
New Clinical Trial Site Added for Clinical Studies of Reqorsa® Gene Therapy to Treat Lung Cancer Acclaim-1 and Acclaim-3 Clinical Trials Supported by FDA Fast Track ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback